Washington – The Food and Drug Administration announced Sunday that it has a legal statement of emergency use of convalescent plasma to treat coronavirus. DR. Stephen Hahn, FDA commissioner, said early trials involve 35% more survival when using convalescent plasma in “optimal patients.”
President Trump held a press convention with Hahn at the White House shortly after the FDA announced emergency approval. The two left while several hounds were shouting “Did you have any effort to authorize this?”
Weijia Jiang of CBS News reported last week that the director of the National Institute of Health, Dr. Francis Collins, the director of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci and NIH members warned Hahn that he was opposed to approving the emergency. authorization of use.
Hahn admitted on Sunday that more knowledge is needed, but said that “obviously this meets the criteria we have set for emergency use authorization.”
Trump, for his part, promoted approval as a “historic announcement” in the opposite fight against COVID-19. Before the press conference, he tweeted that he would announce “very news.”
A day earlier, Trump warned that the FDA’s “deep state” has intentionally delayed trials of a coronavirus vaccine and curative products, with the goal of undermining his prospects for re-election.
“The deep state, or else, at the FDA makes it very difficult for pharmaceutical corporations to test vaccines and treatments. Clearly, they hope to stop the reaction after November 3,” he tweeted.
However, former FDA commissioner Scott Gottlieb said in “Face the Nation” that the trial granting authorization has not been “done very rigorously.”